Getting to the heart of the matter: Precision therapies for age-related neurodegenerative diseases
Presented: September 15, 2021
Pioneering biochemist Jeffery Kelly, PhD, has recently been awarded the prestigious Breakthrough Prize for his transformative advances in the understanding of neurological disease. In his Front Row lecture, Professor Kelly shares his research into a broad set of disorders where incorrectly folded proteins clump and lead to degeneration of the heart and the nervous systems. He explains how his research led to the first approved therapy for diseases caused by such processes. He also describes how he and his team are developing future precision therapies for a wide range of diseases.